Emergent BioSolutions (EBS) Asset Writedowns and Impairment (2010 - 2026)
Emergent BioSolutions (EBS) posted Asset Writedowns and Impairment of $191.3 million for Q2 2026.
Powered by 
Analysis
Emergent BioSolutions (EBS) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Asset Writedowns and Impairment at Emergent BioSolutions was $203.5 million, up 648.2% year-over-year; for FY2025, it was $12.2 million, down 55.1% from FY2024.
- Annual Asset Writedowns and Impairment shows a five-year compound annual growth rate of -15.9% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Asset Writedowns and Impairment was $27.2 million in FY2024 (-91.1%), $306.7 million in FY2023, $6.7 million in FY2022 (-83.9%) and $41.7 million in FY2021 (+43.8%).
- The Q2 2026 figure stands as the highest quarterly Asset Writedowns and Impairment since Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 318.37 Mn | -432.53 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191.30 Mn |
| Dec 31, 2025 | 12.20 Mn |
| Jun 30, 2024 | 27.20 Mn |
| Sep 30, 2023 | 218.20 Mn |
| Jun 30, 2023 | 306.70 Mn |
| Dec 31, 2022 | 6.70 Mn |
| Dec 31, 2021 | 41.70 Mn |
| Dec 31, 2019 | 12.00 Mn |
| Jun 30, 2018 | 229,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Dec 31, 2016 | 1.85 Mn |
| Sep 30, 2016 | 2.64 Mn |
| Sep 30, 2015 | 9.83 Mn |
| Dec 31, 2013 | 1.17 Mn |
| Mar 31, 2012 | 9.60 Mn |
| Dec 31, 2011 | 300,000.00 |
| Dec 31, 2010 | 189,000.00 |
API Access
Emergent BioSolutions Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();